imatinib mesylate has been researched along with Endotoxin Shock in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia, D; Gollard, RP; Ruemmler-Fish, C | 1 |
1 other study(ies) available for imatinib mesylate and Endotoxin Shock
| Article | Year |
|---|---|
Systemic Mastocytosis: documented pathologic response to imatinib.
Topics: Antineoplastic Agents; Benzamides; Bone Marrow; Fatal Outcome; Humans; Imatinib Mesylate; Male; Mastocytosis, Systemic; Middle Aged; Piperazines; Pneumonia; Pyrimidines; Shock, Septic | 2007 |